Opportunity overview
We seek indicative costs from Suppliers who have the capability to purchase or manufacture Ambroxol 420mg tablets for a clinical trial.
Classification
- CPV85149000 — Pharmacy services
Lots
- We seek indicative costs from Suppliers who have the capability to purchase or manufacture Ambroxol 420mg tablets for a clinical trial. <br/>Approximately 44,160 tablets for up to 80 participants will be required for distribution to 11 UK sites, 4 times per year for 2 years. Drugs to be distributed in blister packs.<br/>Indicative costs also required for the production and distribution of an Investigator brochure for the above.<br/>Any indicative costs provided through this Prior Information notice will be used soley to apply for funding for this project and will not be evaluated in any further procurement activity.<br/>We would also like to understand what the supply market looks like, how many suppliers could meet our requirements and what sort of time frames might be required to produce these quantities of Ambroxol.<br/>Funding approval will be required prior to any Tendering exercise and any procurement would also be dependent on regulatory approval from MHRA.<br/>Please note this is not a call for competition but for market engagement purposes only and any pricing received at this stage will have no bearing on any future procurement evaluation.Value not stated